WeQual: Exceptional EMEA Women Executives Shortlisted in Awards
Twenty-four women executives have been recognised by the WeQual Awards for their outstanding contribution to business from some of the biggest companies in the Europe, Middle East and Africa region. WeQual’s mission is to tackle the slow progress in appointing women to executive positions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211108006143/en/
World-Class Women Executives With C-Suite Potential Named in Shortlist for WeQual Awards (Photo: Business Wire)
Since its creation, more than 35% of the winners of previous WeQual Awards in the UK, EMEA, APAC and The Americas have already been promoted to the executive committees of major global companies.
The 24 WeQuals, all one level below Group ExCo or Group C-Suite leader, automatically become members of the WeQual Club. They join the 144 senior executives already enrolled. The winners in each category will be announced in January 2022.
The 24 WeQual Finalists for EMEA 2021:
Technology Category
- Cecile Bartenieff, COO of Global Banking & Investors Solutions and Global Head of Technology & Operations, Société Générale.
- Patricia Beau, Chief Technology Officer Lead / Partner For Consumer Healthcare, Sanofi.
- Miruna Senciuc, CEO, Romanian Branch, BNP Paribas Personal Finance.
Brand Category
- Mia Claselius, Vice President, Head of Communications, ABB Electrification, ABB Ltd.
- Noémie Ellezam, Group Chief Digital Strategy Officer, Société Générale.
- Anjana Srinivasan, Chief Operating Officer – HSBC Global Marketing, HSBC Holdings plc.
Transformation Category
- Naina Bhattacharya, Chief Information Security Officer, Danone.
- Christiane Lindenschmidt, Chief Digital and Data Officer, Markets and Securities Services, HSBC Holdings Plc.
- Chafika Chettaoui, Group Chief Data Officer, Suez.
Commercial Category
- Anne O'Leary, Chief Executive Officer, Vodafone Ireland, Vodafone Group Plc.
- Filipa Martins, Managing Director/CEO, Portugal, Edenred.
- Mieke De Schepper, Executive Vice President and Managing Director, Asia-Pacific, Amadeus IT Group.
Finance Category
- Anna Dimitrova, Chief Financial Officer and Strategy Director of Vodafone Germany
- Daria Dodonova, Chief Financial Officer, Magyar Telekom, Deutsche Telekom.
- Camila Japur, CFO Emerging Businesses, Ericsson.
Business Development Category
- Arancha Cordero, Chief Growth Officer Waters, Danone.
- Susan Uthayakumar, President, Sustainability Business Division, Schneider Electric.
- Bettina Möckel, Vice President Corporate Business Development, QIAGEN.
Procurement & Supply Chain Category
- Sigrid Brendel, Head of Global Procurement, CPO, Campari Group.
- Jessica Nordlinder, Chief Procurement Officer, Essity.
- Francesca Gamboni, Senior Vice President Global Supply Chain Groupe Stellantis, Stellantis.
People & Culture Category
- Audra Jenkins, Chief Diversity & Inclusion Officer, Randstad North America.
- Cecilia Hallengren, Senior Vice President, People and Culture, Volvo Group Trucks Technology, Volvo Group.
- Tina Mylon, SVP, Talent and Diversity, Schneider Electric.
Notes
Quotes available on request.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211108006143/en/
Contact information
Katie Litchfield at katie@wequal.com or go to wequal.com
Mobile: + 44 7796 147466 | UK office: +44 20 3290 3389
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom